eMedicine Specialties > Dermatology > Viral Infections

Hand-Foot-and-Mouth Disease

Author: Brad S Graham, MD, Consulting Staff, Dermatology Associates of Tyler
Contributor Information and Disclosures

Updated: Aug 3, 2009

Introduction

Background

Hand-foot-and-mouth disease (HFMD) is a viral illness with a distinct clinical presentation of oral and characteristic distal extremity lesions. Most commonly, the etiologic agents are coxsackieviruses, members of the Picornaviridae family.

Pathophysiology

Epidemic hand-foot-and-mouth disease (HFMD) viral infections are usually caused by members of the Enterovirus genus, namely, coxsackievirus A16 or enterovirus 71. In addition, sporadic cases with coxsackievirus types A4-A7, A9, A10, B1-B3, and B5 have been reported. Infections usually occur as isolated events, but epidemics occur regularly. An outbreak of HFMD in China during 2003 was caused by echovirus 19.1

The incubation period averages 3-6 days. Coxsackievirus infection is highly contagious. During epidemics, the virus is spread by horizontal transmission from child to child and from mother to fetus. Transmission occurs by means of direct contact with nasal and/or oral secretions, fecal material, or aerosolized droplets in a fecal-oral or oral-oral route. Initial viral implantation in the buccal and ileal mucosa is followed by spread to lymph nodes within 24 hours. Viremia rapidly ensues, with spread to the oral mucosa and skin. By day 7, neutralizing antibody levels increase and the virus is eliminated.

Frequency

United States

HFMD epidemics tend to occur every 3 years in the United States.

International

Worldwide HFMD occurrences are reported. A seasonal pattern is present in temperate climates, with a peak incidence in late summer and early fall.

Mortality/Morbidity

  • Hand-foot-and-mouth disease (HFMD) is more severe in infants and children than adults, but generally, the disease has a mild course.
  • Enteroviral infections may also cause myocarditis, pneumonia, meningoencephalitis, and even death.
  • Rarely, disease recurs.
  • Infection in the first trimester may lead to spontaneous abortion or intrauterine growth retardation.
  • A large outbreak of HFMD in Taiwan caused by enterovirus 71 had a high mortality rate of 19.3% in the severe cases; the deaths resulted from pulmonary hemorrhage. During this outbreak, mortality rates were highest in children younger than 3 years.2
  • In a large epidermic (138 cases) of HFMD related to enterovirus 71 in Singapore, 7 fatalities occurred, most from interstitial pneumonitis or brainstem encephalitis. The report's conclusions were that in general, HFMD is a benign disease but the presence of unusual physical findings, elevated total white blood cell count, and vomiting and the absence of oral ulcers may signify a patient with higher risk of a fatal outcome.3
  • A later study of an HFMD epidermic (14 children) in Australia, again with enterovirus 71, reported that 9 (64%) developed severe neurologic disease in which the host immune response seemed to cause most of the neurologic manifestations.4
  • In one study of an outbreak HFMD in Sarawak, Malaysia caused by human enterovirus 71, the authors identified 3 clinical risk factors to help detect children at risk for neurologic complications. Total duration of fever for 3 or more days, peak temperature elevation greater or equal to 38.5°C, and a history of lethargy all were independently associated with cerebrospinal fluid pleocytosis and neurologic disease.5

Race

No racial predilection is recognized for hand-foot-and-mouth disease.

Sex

The male-to-female ratio for hand-foot-and-mouth disease is 1:1.

Age

Most cases of hand-foot-and-mouth disease affect children younger than 10 years, although cases in adults are reported.

Clinical

History

  • A brief prodrome of 12-36 hours duration is part of the usual presentation of hand-foot-and-mouth disease (HFMD), which consists of the following:
    • Low-grade fever with an average temperature of 38.3°C and duration of 2-3 days
    • Anorexia
    • Malaise
    • Abdominal pain
    • Sore mouth
    • Cough
  • In one study, 80% of the children presented with anorexia and mouth soreness.
  • The enanthem usually precedes the exanthem that is asymptomatic, but both may occur simultaneously.
  • The lesions on the hands and feet are present for 5-10 days.
  • The mucosal and cutaneous lesions heal spontaneously in 5-7 days.

Physical

  • Hand-foot-and-mouth disease (HFMD) is more severe in infants and children than adults, but generally, the disease has a mild course.
    • Symptoms such as malaise, low-grade fever, and anorexia are often present.
    • Occasionally, patients have high fever, marked malaise, diarrhea, and arthralgias.
    • Enteroviral infections may also cause myocarditis, pneumonia, meningoencephalitis, and even death.
    • Rarely, disease recurs. One report describes a 15-year-old white boy with recurrent episodes of HFMD at 3 weeks and 7 months following the initial viral illness.6 The lesions in the recurrent episodes were located in the same distribution as the initial presentation. His workup after the last case revealed an absence of immunodeficiency and a greater than 4-fold increase in coxsackievirus B titers. No serologic evidence of acute infection was identified, and titers of immunoglobulin G remained elevated for 1 year following this third episode.
    • Infection in the first trimester may lead to spontaneous abortion or intrauterine growth retardation.
  • Oral lesions begin as erythematous macules that evolve into 2-3 mm vesicles on an erythematous base.
  • The vesicles are rarely observed because they rapidly become ulcerated.
    • They are painful and may interfere with eating.
    • The total number of ulcers averages 5-10.
  • The vesicles may involve the palate, buccal mucosa, gingiva, and tongue. The tongue is involved in 44% of the cases, and, in addition to the ulcers, the tongue may be edematous and tender.


The lower lip has an ulcer with an erythematous ...

The lower lip has an ulcer with an erythematous halo.

The lower lip has an ulcer with an erythematous ...

The lower lip has an ulcer with an erythematous halo.



The tongue has an ulcer with an erythematous halo.

The tongue has an ulcer with an erythematous halo.

The tongue has an ulcer with an erythematous halo.

The tongue has an ulcer with an erythematous halo.

  • Cutaneous lesions are characteristic and are present in two-thirds of patients.
    • Typically, the hands, feet, and buttocks are involved.
    • The hands are involved more often than the feet, and the dorsal aspect of the hands and sides of the fingers are more commonly involved than the palmar surfaces.
    • Each lesion begins as a 2-10 mm erythematous macule on which a central, gray, oval vesicle develops.
    • The lesions are characteristically elliptical; their long axis parallels the skin lines.
    • These lesions are asymptomatic and resolve in 3-7 days as a result of fluid resorption.


A typical cutaneous lesion has an elliptical vesi...

A typical cutaneous lesion has an elliptical vesicle surrounded by an erythematous halo. The long axis of the lesion is oriented along the skin lines.

A typical cutaneous lesion has an elliptical vesi...

A typical cutaneous lesion has an elliptical vesicle surrounded by an erythematous halo. The long axis of the lesion is oriented along the skin lines.

  • Erythematous maculopapular eruptions may also occur on the buttocks and arms.
  • In one report, 22% of the patients also had marked cervical or submandibular lymphadenopathy.

Causes

  • Epidemic hand-foot-and-mouth disease (HFMD) infections are usually caused by coxsackievirus A16 or enterovirus 71.
  • In addition, sporadic cases with coxsackievirus types A4-A7, A9, A10, B1-B3, and B5 are reported.
  • An outbreak of hand-foot-and-mouth disease in China during 2003 was caused by echovirus 19.1

More on Hand-Foot-and-Mouth Disease

Overview: Hand-Foot-and-Mouth Disease
Differential Diagnoses & Workup: Hand-Foot-and-Mouth Disease
Treatment & Medication: Hand-Foot-and-Mouth Disease
Follow-up: Hand-Foot-and-Mouth Disease
Multimedia: Hand-Foot-and-Mouth Disease
References

References

  1. Zhu Z, Xu WB, Xu AQ, et al. Molecular epidemiological analysis of echovirus 19 isolated from an outbreak associated with hand, foot, and mouth disease (HFMD) in Shandong Province of China. Biomed Environ Sci. Aug 2007;20(4):321-8. [Medline].

  2. Chang LY, King CC, Hsu KH, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics. Jun 2002;109(6):e88. [Medline][Full Text].

  3. Chong CY, Chan KP, Shah VA, et al. Hand, foot and mouth disease in Singapore: a comparison of fatal and non-fatal cases. Acta Paediatr. Oct 2003;92(10):1163-9. [Medline].

  4. McMinn P, Stratov I, Nagarajan L, Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. Jan 15 2001;32(2):236-42. [Medline].

  5. Ooi MH, Wong SC, Mohan A, et al. Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect Dis. Jan 19 2009;9:3. [Medline][Full Text].

  6. Sutton-Hayes S, Weisse ME, Wilson NW, Ogershok PR. A recurrent presentation of hand, foot, and mouth disease. Clin Pediatr (Phila). May 2006;45(4):373-6.

  7. Tsao KC, Chang PY, Ning HC, et al. Use of molecular assay in diagnosis of hand, foot and mouth disease caused by enterovirus 71 or coxsackievirus A 16. J Virol Methods. Apr 2002;102(1-2):9-14. [Medline].

  8. Yang Y, Wang H, Gong E, et al. Neuropathology in 2 cases of fatal enterovirus type 71 infection from a recent epidemic in the People's Republic of China: a histopathologic, immunohistochemical, and reverse transcription polymerase chain reaction study. Hum Pathol. Apr 22 2009;[Medline].

  9. Faulkner CF, Godbolt AM, DeAmbrosis B, Triscott J. Hand, foot and mouth disease in an immunocompromised adult treated with aciclovir. Australas J Dermatol. Aug 2003;44(3):203-6. [Medline].

  10. Toida M, Watanabe F, Goto K, Shibata T. Usefulness of low-level laser for control of painful stomatitis in patients with hand-foot-and-mouth disease. J Clin Laser Med Surg. Dec 2003;21(6):363-7. [Medline].

  11. Adams SP. Dermacase. Hand-foot-and-mouth disease. Can Fam Physician. May 1998;44:985, 993. [Medline].

  12. Ferson MJ, Bell SM. Outbreak of Coxsackievirus A16 hand, foot, and mouth disease in a child day-care center. Am J Public Health. Dec 1991;81(12):1675-6. [Medline].

  13. Hood AF, Mihm MC. Hand-foot-and-mouth disease. In: Fitzpatrick TB, Austen KF, Wolff K, Eisen AZ, Freedberg IM, eds. Dermatology in General Medicine. 4th ed. New York, NY: McGraw-Hill; 1993:2521-3.

  14. Hurwitz S. The exanthematous diseases of childhood. In: Hurwitz, ed. Clinical Pediatric Dermatology: A Textbook of Skin Disorders of Childhood and Adolescence. 2nd ed. Philadelphia, Pa: WB Saunders; 1993:359-61.

  15. Thomas I, Janniger CK. Hand, foot, and mouth disease. Cutis. Nov 1993;52(5):265-6. [Medline].

Further Reading

Contributor Information and Disclosures

Author

Brad S Graham, MD, Consulting Staff, Dermatology Associates of Tyler
Brad S Graham, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society of Dermatopathology, and Texas Dermatological Society
Disclosure: Nothing to disclose.

Medical Editor

Bernice R Krafchik, MBChB, FRCPC, Professor Emeritus, Department of Pediatrics, Section of Dermatology, University of Toronto
Bernice R Krafchik, MBChB, FRCPC is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, Canadian Medical Association, College of Physicians and Surgeons of Ontario, Royal College of Physicians and Surgeons of Canada, and Society for Pediatric Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Edward F Chan, MD, Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania School of Medicine
Edward F Chan, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

CME Editor

Catherine M Quirk, MD, Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania
Catherine M Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.